Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 300 of 465 entries
View as:

A Study of the Safety and Efficacy of Long-term Correction of Anemia With Epoetin Alfa in Early Hemodialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT00261521 Org: User:
Start: 02/29/00 End: 05/31/03 Due: 05/31/04

A Study of the Safety and Effectiveness of Topiramate on Insulin Sensitivity in Overweight or Obese Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00236626 Org: User:
Start: 04/30/00 End: 05/31/02 Due: 05/31/03

An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00809965 Org: User:
Start: 11/30/08 End: 09/30/11 Due: 09/30/12

Treatment of Anemic Patients With Cancer Who Are Not Receiving Chemotherapy or Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00083434 Org: User:
Start: 02/29/04 End: 10/31/04 Due: 10/31/05

A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of JNJ-28431754 in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01177163 Org: User:
Start: 05/31/08 End: 03/31/09 Due: 03/31/10

A Study of Canagliflozin in Study Participants With Various Degrees of Impaired Hepatic (Liver) Function

Phase: N/A Priority: Normal
NCT ID: NCT01186588 Org: User:
Start: 08/31/10 End: 04/30/11 Due: 04/30/12

The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00270101 Org: User:
Start: 01/31/95 End: 09/30/96 Due: 09/30/97

A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00236457 Org: User:
Start: 11/30/00 End: 12/31/02 Due: 12/31/03

An Efficacy and Safety Study of Topiramate in the Treatment of Alcohol Dependence

Phase: N/A Priority: Normal
NCT ID: NCT00210925 Org: User:
Start: 03/31/04 End: 08/31/06 Due: 08/31/07

A Study of the Safety and Effectiveness of Canagliflozin (JNJ-28431754) in Promoting Weight Loss in Overweight and Obese Patients Who do Not Have Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00650806 Org: User:
Start: 05/31/08 End: 09/30/08 Due: 09/30/09

A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of of JNJ-31001074 in Children (6-11 Years) With Attention Deficit Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT00890240 Org: User:
Start: 05/31/09 End: 11/30/09 Due: 11/30/10

Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00063297 Org: User:
Start: 05/31/03 End: 10/31/03 Due: 10/31/04

A Study of QT and QTc Intervals in Patients Administered Immediate Release Paliperidone

Phase: N/A Priority: Normal
NCT ID: NCT00791349 Org: User:
Start: 02/28/05 End: 05/31/05 Due: 05/31/06

A Study of the Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00253149 Org: User:
Start: - End: 04/30/99 Due: 04/30/00

A Study of Cisapride in Patients With Symptomatic Gastro-Oesophageal Reflux Disease

Phase: N/A Priority: Normal
NCT ID: NCT01281553 Org: User:
Start: 09/30/03 End: 10/31/03 Due: 10/31/04

A Single and Multiple Dose Study to Explore the Safety Of JNJ-40346527 In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01054014 Org: User:
Start: 01/31/10 End: 01/31/11 Due: 01/31/12

A Drug Interaction Study of JNJ-31001074 and Ketoconazole in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00915746 Org: User:
Start: 11/30/09 End: 12/31/09 Due: 12/31/10

A Study of Trabectedin in Patients With Advanced Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00050414 Org: User:
Start: 10/31/02 End: 09/30/05 Due: 09/30/06

A Study to Compare the Bioequivalence of 50-mg Tapentadol (CG5503) Dose Administered as Two 50-mg Tablets Relative to One 100-mg Tablet

Phase: N/A Priority: Normal
NCT ID: NCT01273532 Org: User:
Start: 12/31/10 End: 03/31/11 Due: 03/31/12

A Study of QT and QTc Intervals in Patients Administered Extended Release Paliperidone or Quetiapine

Phase: N/A Priority: Normal
NCT ID: NCT00791622 Org: User:
Start: 01/31/06 End: 06/30/06 Due: 06/30/07

A Safety Study of Epoetin Alfa in Patients With Cancer Who Have Chemotherapy-Related Anemia

Phase: N/A Priority: Normal
NCT ID: NCT01394991 Org: User:
Start: 01/31/06 End: 09/30/09 Due: 09/30/10

A Comparison of the Effectiveness and Safety of Levofloxacin to That of Ciprofloxacin in Treating Complicated Urinary Tract Infection and Acute Pyelonephritis.

Phase: N/A Priority: Normal
NCT ID: NCT00210886 Org: User:
Start: 10/31/04 End: 04/30/06 Due: 04/30/07

Alternate Dosing - Initiation of Every 2 Week Epoetin Alfa (PROCRIT) in the Treatment of Anemia.

Phase: N/A Priority: Normal
NCT ID: NCT00210743 Org: User:
Start: 05/31/04 End: 10/31/05 Due: 10/31/06

A Study to Compare the Safety and Effectiveness of 2 Doses of Levofloxacin Given for Different Time Periods in Patients With Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT00236821 Org: User:
Start: 03/31/01 End: 06/30/02 Due: 06/30/03

An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT00403767 Org: User:
Start: 12/31/06 End: 09/30/10 Due: 09/30/11